Breast cancer

ANTWERP, Belgium - - Leading Cancer Groups and Archbishop Desmond Tutu Unite in Call to Action in the Fight Against Prostate Cancer ANTWERP, Belgium, September 17 /PRNewswire/ -- A coalition of influential European advocacy and professional groups are meeting today to call for action by the European Parliament to commit to serious steps to reduce the number of men affected by, and dying from prostate cancer, by ensuring timely access to information, care and support services for men at risk or with prostate cancer.

PARIS and BRISBANE, California - Data Highlighted in Plenary Session of 2009 American Society of Clinical Oncology Annual Meeting Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and its fully owned subsidiary, BiPar Sciences, today announced results from a randomized Phase 2 clinical trial of BSI-201, a poly ADP-ribose polymerase (PARP) inhibitor, in combination with gemcitabine and carboplatin (GC) chemotherapy, in patients with metastatic triple-negative breast cancer (TNBC).

MARSEILLE, France - The Genomic HR Test Will Help Pathologists to Identify Endocrine-Responsive Tumors That Should Benefit From Hormonotherapy Ipsogen SA (Alternext - FR0010626028 - ALIPS), a molecular diagnostic company specialized in the development, manufacturing and commercialization of diagnostic assays for breast cancer and leukemia, today announces the European launch of the MapQuant Dx(TM) HR test.

LONDON - Analog screening systems are gradually being replaced by digital mammography systems.

NEW YORK - Medidata Solutions Chosen for Flexible, Fast and Cost-Effective Implementation and eLearning Capabilities Medidata Solutions, a leading global provider of hosted clinical development solutions, today announced that U-Systems, Inc.